Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2017

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension

Jens Preussner
  • Fonction : Auteur
Soni Pullamsetti
Jörg Tost
  • Fonction : Auteur
  • PersonId : 912248
Jean-François Deleuze
  • Fonction : Auteur
  • PersonId : 1015006
Werner Seeger
  • Fonction : Auteur
  • PersonId : 873333
David Montani
  • Fonction : Auteur
  • PersonId : 944435
Frédéric Perros


Pulmonary arterial hypertension (PAH) is a severe and incurable pulmonary vascular disease. One of the primary origins of PAH is pulmonary endothelial dysfunction leading to vasoconstriction, aberrant angiogenesis and smooth muscle cell proliferation, endothelial-to-mesenchymal transition, thrombosis and inflammation. Our objective was to study the epigenetic variations in pulmonary endothelial cells (PEC) through a specific pattern of DNA methylation. DNA was extracted from cultured PEC from idiopathic PAH (n = 11), heritable PAH (n = 10) and controls (n = 18). DNA methylation was assessed using the Illumina HumanMethylation450 Assay. After normalization, samples and probes were clustered according to their methylation profile. Differential clusters were functionally analyzed using bioinformatics tools. Unsupervised hierarchical clustering allowed the identification of two clusters of probes that discriminates controls and PAH patients. Among 147 differential methylated promoters, 46 promoters coding for proteins or miRNAs were related to lipid metabolism. Top 10 up and down-regulated genes were involved in lipid transport including ABCA1, ABCB4, ADIPOQ, miR-26A, BCL2L11. NextBio meta-analysis suggested a contribution of ABCA1 in PAH. We confirmed ABCA1 mRNA and protein downregulation specifically in PAH PEC by qPCR and immunohistochemistry and made the proof-of-concept in an experimental model of the disease that its targeting may offer novel therapeutic options. In conclusion, DNA methylation analysis identifies a set of genes mainly involved in lipid transport pathway which could be relevant to PAH pathophysiology.
Fichier principal
Vignette du fichier
2017 Hautefort et al., Pulmonary endothelial cell.pdf (94.8 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-01832105 , version 1 (08-04-2020)



Aurélie Hautefort, Julie Chesné, Jens Preussner, Soni Pullamsetti, Jörg Tost, et al.. Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension. Oncotarget, 2017, 8 (32), pp.52995-53016. ⟨10.18632/oncotarget.18031⟩. ⟨hal-01832105⟩
410 Consultations
36 Téléchargements



Gmail Mastodon Facebook X LinkedIn More